Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
FDA Approves Margetuximab Plus Chemotherapy in HER2+ Metastatic Breast Cancer
The FDA granted approval to the Fc-engineered, monoclonal antibody margetuximab in combination with chemotherapy, as treatment of adult patients with metastatic HER2-positive breast cancer who have re...
Novo Holdings establishes rare bleeding disorder firm Hemab
Novo Holdings’ early-stage investment and company creation team Novo Seeds has established a new portfolio company – Hemab – which will focus on the development of bispecific antibodies for rare...
Israel begins second-phase trial of potential COVID-19 vaccine
JERUSALEM (Reuters) - Israel said on Monday it was beginning a second-phase trial with 1,000 people for its COVID-19 vaccine candidate which, if successful, could be ready for the general publ...
No more pills every day: New injection for HIV ‘acts like a short-term AIDS vaccine’
A large clinical trial of African women has led to a major breakthrough in the prevention of HIV – a long-lasting injectable drug that, according to Science, “acts like a short-term AIDS vaccine.
BioNTech and Fosun Pharma to Supply China with mRNA-based COVID-19 Vaccine
MAINZ, GERMANY, and SHANGHAI, CHINA, December 16, 2020 (GLOBE NEWSWIRE) — BioNTech SE (Nasdaq.
Lilly makes another gene therapy play with $1B deal to buy Prevail TX
Eli Lilly has joined the ranks of big pharma companies building a position in gene therapy, paying $26.
Harper, Seidenberg's Westlake Village BioPartners reels in $500M across 2 funds
When Amgen vets Beth Seidenberg, M.
Regeneron's blood cancer hopeful odronextamab hit with FDA partial hold across several trials
The FDA has told Regeneron to hit the brakes on its experimental blood cancer drug trial over safety concerns.
Green light for UK trial of nasal coronavirus vaccine
Open Orphan and Codagenix have received approval from the UK’s independent Medicines and Healthcare Products Regulatory Agency (MHRA) to conduct a Phase I study of its COVID-19 vaccine.
Update on The University of Queensland COVID-19 vaccine
The University of Queensland (UQ) and CSL today announce that the Phase 1 trial of the UQ-CSL v451 COVID-19 vaccine has shown that it elicits a robust response towards the virus and has a stro...
Trial of ruxolitinib in COVID-19 complications fails - Novartis
ZURICH (Reuters) - Novartis said a late-stage clinical trial of ruxolitinib on top of standard therapy showed no significant reduction in severe complications of COVID-19, including death, res...
Coronavirus: US begins vaccine shipments
The United States has kicked off a massive logistical effort to distribute coronavirus vaccines across the country.
263
264
265
266
267
268
269
270
271
